DE3852236D1 - Verfahren zur Kontrolle der Leukozyten-Extravasation. - Google Patents

Verfahren zur Kontrolle der Leukozyten-Extravasation.

Info

Publication number
DE3852236D1
DE3852236D1 DE3852236T DE3852236T DE3852236D1 DE 3852236 D1 DE3852236 D1 DE 3852236D1 DE 3852236 T DE3852236 T DE 3852236T DE 3852236 T DE3852236 T DE 3852236T DE 3852236 D1 DE3852236 D1 DE 3852236D1
Authority
DE
Germany
Prior art keywords
leukocyte
specific
cell surface
synovial
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3852236T
Other languages
English (en)
Other versions
DE3852236T2 (de
Inventor
Eugene C Butcher
Sirpa T Jalkanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of DE3852236D1 publication Critical patent/DE3852236D1/de
Application granted granted Critical
Publication of DE3852236T2 publication Critical patent/DE3852236T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3852236T 1987-08-11 1988-08-10 Verfahren zur Kontrolle der Leukozyten-Extravasation. Expired - Fee Related DE3852236T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8449087A 1987-08-11 1987-08-11
US8447887A 1987-08-11 1987-08-11

Publications (2)

Publication Number Publication Date
DE3852236D1 true DE3852236D1 (de) 1995-01-12
DE3852236T2 DE3852236T2 (de) 1995-04-06

Family

ID=26771020

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3852236T Expired - Fee Related DE3852236T2 (de) 1987-08-11 1988-08-10 Verfahren zur Kontrolle der Leukozyten-Extravasation.

Country Status (5)

Country Link
EP (1) EP0303463B1 (de)
JP (1) JPH02196A (de)
AT (1) ATE114478T1 (de)
CA (1) CA1340202C (de)
DE (1) DE3852236T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04504501A (ja) * 1988-12-23 1992-08-13 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ ホーミング配列およびそれらの使用
DE4134982A1 (de) * 1991-10-23 1993-04-29 Kernforschungsz Karlsruhe Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
US7803904B2 (en) 1995-09-01 2010-09-28 Millennium Pharmaceuticals, Inc. Mucosal vascular addressing and uses thereof
US7750137B2 (en) 1995-09-01 2010-07-06 Millennium Pharmaceuticals, Inc. Mucosal vascular addressins
US6551593B1 (en) 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
UY34054A (es) 2011-05-02 2012-11-30 Millennium Pharm Inc FORMULACIÓN PARA ANTICUERPO ANTI-a(alfa)4B(Beta)7

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110610A1 (de) * 1981-03-18 1982-10-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Chemokinesine und chemotaxine der leukozyten und des entzuendungsgewebes: natuerliche mediatoren zur selektiven reversiblen motilitaetsbeinflussung (chemokinesis) und chemische anlockung (chemotaxis) bei der ansammlung von leukozyten

Also Published As

Publication number Publication date
EP0303463A3 (en) 1990-04-04
EP0303463B1 (de) 1994-11-30
CA1340202C (en) 1998-12-15
JPH02196A (ja) 1990-01-05
EP0303463A2 (de) 1989-02-15
DE3852236T2 (de) 1995-04-06
ATE114478T1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
DE19975064I2 (de) Tumornekrosefaktor, Verfahren zu seiner Herstellung, denselben enthaltende Zusammensetzungen, daf}r kodierende DNS und diese DNS verwendendes Testverfahren.
DE69727595D1 (de) Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
ATE153696T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
DE69124838D1 (de) Verfahren zur Herstellung von Polysiloxanemulsionen
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE83252T1 (de) Verfahren zur herstellung kolloidaler suspensionen von organopolysiloxanen.
DE69102401D1 (de) Verfahren zur Herstellung von kappa-Casein-Glycomakropeptid.
ATE78483T1 (de) Verfahren zur herstellung von methacryloxyoder acryloxyorganosilanen oder -organosiliconen.
ATE110265T1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DE69325948T2 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
DE3852236D1 (de) Verfahren zur Kontrolle der Leukozyten-Extravasation.
DE69311183D1 (de) Verfahren zur Herstellung von Acryloxy- oder Methacryloxygruppen enthaltenden Organosiliconen
DE69319012T2 (de) Protein mit Knochenbildungs-Eigenschaften und Verfahren zu seiner Herstellung
DE3884644D1 (de) Verfahren zur Herstellung von 5'-Inosinsäure.
PT817851E (pt) Dna codificador do virus do papiloma humano tipo 18
DE3880194D1 (de) Zyklisches antikoagulierendes peptid.
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE69132413D1 (de) Verfahren zur Herstellung von Emulsionen
DE69025100D1 (de) Verfahren zur Herstellung von Polycarbonaten mit kontrolliertem Molekulargewicht aus Bischloroformiaten
ATE11224T1 (de) Wundheilende zusammensetzungen.
DE3881467D1 (de) Vasokonstriktor-peptid.
DE68915067D1 (de) Verfahren zur Herstellung von 2'-Deoxy-beta-adenosin.
ATE43610T1 (de) Acino-foetale differenzierungsproteine verbunden mit krebs des pankreas, antiserum und monoklonale antikoerper gegen diese proteine und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee